[新型口服抗凝药的解毒剂：现实与期望] - Suppr

[Antidotes for the new oral anticoagulants: Reality and expectations].

作者信息

Gómez-Outes Antonio, Lecumberri Ramón

机构信息

División de Farmacología y Evaluación Clínica, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Madrid, España.

Servicio de Hematología, Clínica Universidad de Navarra, Pamplona, Navarra, España.

出版信息

Med Clin (Barc). 2016 Jun 3;146(11):488-90. doi: 10.1016/j.medcli.2015.11.014. Epub 2016 Jan 6.

DOI:10.1016/j.medcli.2015.11.014

PMID:26776485

Abstract

摘要

相似文献

[Antidotes for the new oral anticoagulants: Reality and expectations].

Med Clin (Barc). 2016 Jun 3;146(11):488-90. doi: 10.1016/j.medcli.2015.11.014. Epub 2016 Jan 6.

When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH.

J Thromb Haemost. 2016 Mar;14(3):623-7. doi: 10.1111/jth.13227. Epub 2016 Feb 17.

Reversal of direct oral anticoagulants.

Br J Hosp Med (Lond). 2017 Mar 2;78(3):165-169. doi: 10.12968/hmed.2017.78.3.165.

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab.

Vasc Health Risk Manag. 2016 Feb 17;12:35-44. doi: 10.2147/VHRM.S89130. eCollection 2016.

Reversal agents for non-vitamin K antagonist oral anticoagulants.

Nat Rev Cardiol. 2018 May;15(5):273-281. doi: 10.1038/nrcardio.2017.223. Epub 2018 Jan 18.

Antidotes for reversal of direct oral anticoagulants.

Pharmacol Ther. 2019 Dec;204:107405. doi: 10.1016/j.pharmthera.2019.107405. Epub 2019 Sep 12.

Introduction to direct oral anticoagulants and rationale for specific reversal agents.

Am J Emerg Med. 2016 Nov;34(11S):1-2. doi: 10.1016/j.ajem.2016.09.045. Epub 2016 Sep 28.

Reversal of direct oral anticoagulants.

Vasc Health Risk Manag. 2017 Jul 19;13:287-292. doi: 10.2147/VHRM.S138890. eCollection 2017.

Antidotes for novel oral anticoagulants: current status and future potential.

Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1736-45. doi: 10.1161/ATVBAHA.114.303402. Epub 2015 Jun 18.

Advances in Stroke 2017.

Stroke. 2018 May;49(5):e174-e199. doi: 10.1161/STROKEAHA.118.021380. Epub 2018 Apr 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Antidotes for the new oral anticoagulants: Reality and expectations].

作者信息

Gómez-Outes Antonio, Lecumberri Ramón

机构信息

División de Farmacología y Evaluación Clínica, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Madrid, España.

Servicio de Hematología, Clínica Universidad de Navarra, Pamplona, Navarra, España.

出版信息

Med Clin (Barc). 2016 Jun 3;146(11):488-90. doi: 10.1016/j.medcli.2015.11.014. Epub 2016 Jan 6.

DOI:10.1016/j.medcli.2015.11.014

PMID:26776485

Abstract

摘要

相似文献

[Antidotes for the new oral anticoagulants: Reality and expectations].

Med Clin (Barc). 2016 Jun 3;146(11):488-90. doi: 10.1016/j.medcli.2015.11.014. Epub 2016 Jan 6.

When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH.

J Thromb Haemost. 2016 Mar;14(3):623-7. doi: 10.1111/jth.13227. Epub 2016 Feb 17.

Reversal of direct oral anticoagulants.

Br J Hosp Med (Lond). 2017 Mar 2;78(3):165-169. doi: 10.12968/hmed.2017.78.3.165.

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab.

Vasc Health Risk Manag. 2016 Feb 17;12:35-44. doi: 10.2147/VHRM.S89130. eCollection 2016.

Reversal agents for non-vitamin K antagonist oral anticoagulants.

Nat Rev Cardiol. 2018 May;15(5):273-281. doi: 10.1038/nrcardio.2017.223. Epub 2018 Jan 18.

Antidotes for reversal of direct oral anticoagulants.

Pharmacol Ther. 2019 Dec;204:107405. doi: 10.1016/j.pharmthera.2019.107405. Epub 2019 Sep 12.

Introduction to direct oral anticoagulants and rationale for specific reversal agents.

Am J Emerg Med. 2016 Nov;34(11S):1-2. doi: 10.1016/j.ajem.2016.09.045. Epub 2016 Sep 28.

Reversal of direct oral anticoagulants.

Vasc Health Risk Manag. 2017 Jul 19;13:287-292. doi: 10.2147/VHRM.S138890. eCollection 2017.

Antidotes for novel oral anticoagulants: current status and future potential.

Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1736-45. doi: 10.1161/ATVBAHA.114.303402. Epub 2015 Jun 18.

Advances in Stroke 2017.

Stroke. 2018 May;49(5):e174-e199. doi: 10.1161/STROKEAHA.118.021380. Epub 2018 Apr 18.

[Antidotes for the new oral anticoagulants: Reality and expectations].

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

[Antidotes for the new oral anticoagulants: Reality and expectations].

作者信息

机构信息

出版信息

相似文献